Number of the day - 98.7% success rate

"Johnson & Johnson MedTech announced results from a study of its Monarch platform for robotic bronchoscopy procedures.  Results from the TARGET study showed that clinicians could reach small and peripherally located lung nodules in more than 98% of cases with Monarch. They also biopsied those nodules with a safety profile compared to non-robotic bronchoscopy procedures. Investigators published findings in the journal CHEST.  TARGET looked at 679 patients across 21 global sites in the U.S., Canada and Hong Kong, Johnson & Johnson MedTech said. The study aimed to measure safety, navigation success and diagnostic yield across a broad range of patients in a real-world setting. Investigators reported reaching the lesion with Monarch in 98.7% of cases and a diagnostic yield of 83.2%." 

Source: MassDevice